Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04927338 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT04927338 · ClinicalTrials.gov record · last posted 2025-07-04

Study of Bacopa in Gulf War Illness Patients

StatusRecruiting
PhasePhase 2
Started2022-12-01
View on ClinicalTrials.gov ↗
Record status
This record was last updated July 4, 2025 (before its estimated April 2026 completion). Its status may not reflect the trial's current state.
from the ClinicalTrials.gov record
Gulf War Illness is a condition that affects multiple major organ systems, resulting in a diverse array of symptoms that include debilitating fatigue, memory and cognition difficulties, headaches, sleep disturbances, gastrointestinal problems, skin rashes, and musculoskeletal/joint pain. This phase II, double masked, randomized, placebo-controlled, two-arm study will evaluate cognitive function as evidence of efficacy of the nutraceutical intervention, Bacopa, on central nervous system symptom management of Gulf War Illness, along with assessments of safety of the intervention.

Amendment record 8 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 8 times since 2021-06-14; most recent amendment 2025-07-02. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2022-12-06
Status change Not Yet Recruiting→Recruitingv3
Trial Details
NCT Number NCT04927338
Lead Sponsor Nova Southeastern University
Collaborators: RTI International, Boston University
Conditions Gulf War Illness
Enrollment 170 participants
Start Date 2022-12-01
Primary Completion 2026-04 (estimated)
Study Completion 2026-04 (estimated)
Updated on ClinicalTrials.gov 2025-07-04